Drug intelligence / Profile preview

Cefotaxime and Clindamycin (combination)

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Parenteral, Intravenous
01

Overview

Cefotaxime and clindamycin is a combination of two antibiotics that are often used together for treating certain types of infections, particularly polymicrobial infections. This combination leverages the complementary antimicrobial spectra of both drugs to provide broader coverage against various pathogens. ## Pharmacology and Mechanism of Action Cefotaxime is a third-generation cephalosporin antibiotic that works against a wide range of gram-positive and gram-negative bacteria[7][9]. It's a semisynthetic, broad-spectrum antibiotic administered parenterally[7]. Clindamycin is a lincosamide antibiotic particularly effective against anaerobic bacteria and certain gram-positive organisms[3][6][8]. It works by inhibiting bacterial protein synthesis. ## Clinical Applications The combination of cefotaxime and clindamycin is particularly useful for: - **Mixed infections**: Cefotaxime is recommended for mixed infections in combination with metronidazole or clindamycin[5]. - **Polymicrobial soft-tissue infections**: Studies have shown that cefotaxime is at least as effective as the combination of gentamicin and clindamycin in treating these infections[2]. - **Skin and soft tissue infections**: Both antibiotics are effective against skin and soft tissue infections, with clindamycin being particularly valuable for severe streptococcal infections[6][8]. - **Necrotizing fasciitis**: Clindamycin is often the drug of choice, combined with other antibiotics, for severe group A streptococcal infections[6]. - **Diabetic foot infections**: Clindamycin is considered the drug of choice for moderate to severe diabetic foot infections, usually combined with a quinolone[6]. ## Dosing Considerations For mixed infections requiring both antibiotics: - **Adults**: Cefotaxime is typically administered as 2g IV every 6-8 hours, while clindamycin dosing varies by indication[5]. - **Children**: Cefotaxime is dosed at 50 mg/kg/dose (maximum 2g/dose) IV divided every 6 hours, combined with clindamycin for mixed infections[5]. - **Neonates**: Dosing is adjusted based on gestational age and postnatal age[5]. ## Drug Interactions Both antibiotics have their own interaction profiles: - Cefotaxime has 57 known drug interactions (5 major, 52 moderate), 6 disease interactions, and 1 alcohol/food interaction[1][4]. - Clindamycin has interactions with various medications and should be used with caution in certain patient populations[8]. ## Safety Considerations - Cefotaxime appears to be somewhat safer than the gentamicin-clindamycin combination, particularly regarding renal function[2]. - Clindamycin has been associated with potentially fatal colitis, so its use should generally be reserved for serious infections when less toxic alternatives cannot be used[8]. The combination of these antibiotics provides effective coverage against a wide spectrum of pathogens, making it valuable for treating complex, polymicrobial infections.

02

Targets

23S rRNA (23S ribosomal RNA)PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Cefotaxime and Clindamycin (combination).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cefotaxime and Clindamycin (combination).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call